Europe – MDCG 2022-14 – Transition to the MDR and IVDR – Notified body capacity and availability of medical devices and IVDs

The MDCG recognises that significant and urgent challenges remain in ensuring sufficient
capacity of notified bodies and readiness of manufacturers in order to allow medical devices
and in vitro diagnostic medical devices to be certified in accordance with the MDR and the
IVDR within the transition periods provided for in the Regulations. The data gathered to date indicate that there are multiple causes which require a mix of solutions…